• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Guttman Buschner LLP

  • Home
  • Areas of Practice
    • High Impact Litigation
    • Whistleblower and False Claim Cases
    • Personal Injury & Wrongful Death
    • Employment Litigation and Civil Rights – Employees
    • Employment Counseling and Litigation – Employers
    • Dispute Resolution and Investigation
    • Corporate Governance
  • Successes
  • Articles
  • Attorneys & Advisors
    • Reuben A. Guttman
    • Traci L. Buschner
    • Judge Nancy Gertner (Ret.)
    • Dan Guttman
    • Elizabeth H. Shofner
    • Dr. Lisa Wollman, MD
    • Rick Mountcastle
  • CLE Seminars
  • Amicus
  • Videos
  • Contact Us
    • Twitter
    • Facebook
    • LinkedIn

Articles

June 16, 2026 By Staff

State-backed whistleblower suit claims neglect in Delaware prison care

A whistleblower lawsuit that has been hidden from public view for nearly three years claims a private contractor paid hundreds of millions of dollars to provide healthcare to prisoners in Delaware covered up deficiencies in care that neglected, maimed, and caused undue suffering to people imprisoned by the state.

Now, Delaware’s Attorney General is joining that whistleblower lawsuit against the state’s former prison healthcare provider, according to recently unsealed court filings.

Centurion was paid some $200 million by the state over three years to provide primary healthcare and mental health services to more than 4,000 prisoners in Delaware ending in 2023. At the time, Centurion was a subsidiary of Centene Corp, a Fortune 25 company and the nation’s largest insurer for the country’s Medicaid program.

Both companies are named as defendants and did not reply to multiple requests for comment through their media and investor teams as well as legal counsel over multiple days.

The lawsuit accuses the business of falsifying records, propping up mental health programs they knew were accomplishing nothing, funneling prisoners toward addiction to and covering-up staffing shortages in a way that denied prisoners adequate healthcare.

“It needs to change,” said Christopher Craig, a prisoner at Howard R. Young Correctional Institution who has spent 31 years in Delaware lockup. “It has gotten worse and it needs to be fixed.”

Horror stories told by prisoners, lawsuits filed on their behalf and at least one government report have for years painted correctional healthcare in Delaware as broken and the cause of suffering.

But this lawsuit is unique.

It was filed in 2023 by two former mental healthcare providers employed by Centurion at Sussex Correctional Institution under a special form of litigation designed to incentivize people to point out fraud perpetuated against the government.

Since its filing, the lawsuit has remained hidden from public view under a court-ordered seal while the office of Delaware Attorney General Kathy Jennings investigated the allegations and eventually decided the state would intervene in the litigation as the defrauded party.

Jennings office declined comment citing the pending litigation. The Delaware Department of Correction, which oversees the delivery of healthcare by private companies, is not named as a defendant and also declined comment.

The state joining the lawsuit represents a remarkable endorsement of the allegations and what prisoners and their families have said for years: the common business model for prison healthcare in Delaware and the United States generally anticipates and prolongs suffering for profitability.

“Centurion’s business model is premised on profit reaped through the denial of basic healthcare and behavioral healthcare required by government contracts,” the lawsuit states.

Centurion enters after scandalous divorce:

State officials hailed Centurion entrance into Delaware’s prisons as a reform as the state divorced its prior, scandal-ridden healthcare provider Connections Community Support Programs Inc.

After years of lawsuits, complaints by prisoners and outside medical providers, Delaware terminated its contract with Connections early. Eventually, the once politically connected non-profit was also sued for defrauding government through drug treatment programs administered outside of Delaware’s prisons. That lawsuit was settled.

At the time, then Department of Correction Commissioner Claire DeMatteis said Centurion would be more professional and better staffed than Connections.

Centurion was selected over other bidders under three-year, extendable contracts that would pay the company $47 million annually to provide basic healthcare services in the prison and $21 million annually to provide mental healthcare as well as drug and alcohol abuse rehab programs.

Centurion operated under the common model for healthcare in American prisons. They bid a certain amount to provide the service; they are paid by taxpayers in monthly instalments and whatever money is left after healthcare is delivered is the company’s profit.

And despite prisoners being financially destitute, Medicaid does not pay for their healthcare unless they are hospitalized for more than 24 hours. Critics say this setup incentivizes shortchanging care, especially expensive specialty care and care that requires an outside doctor.

The company’s basic task is to employ healthcare professionals to provide primary care inside prisons: to make diagnosis and treatment plans, manager prisoners’ medication, provide what care is possible inside the prison and refer people to outside specialists when needed.

The mental health contract is similar and mandated the company administer special programs for substance use disorders which are often linked to a person’s eventual release from prison.

The contract included provisions outlining minimum staffing levels, basic training and qualifications for staff, requirements for the administration of rehabilitation programs that prisoners and provisions for officials to withhold payment if the company didn’t adequately perform these tasks. 

The lawsuit states that these contractual agreements were “lies” by the company.  

“Centurion’s assurances about the treatment and rehabilitation it would provide were false, and it conspired to conceal these shortfalls from the Department of Correction,” the lawsuit states. 

The whistleblowers’ allegations:

Deneen Rayne and Jamie Basara, the two whistleblowers who instigated the lawsuit, both worked for Centurion as substance abuse counselors at Sussex Correctional Institution near Georgetown.

They were part of what was known as the Road to Recovery program, a rehabilitation program that judges order some prisoners to complete during their sentence.

The lawsuit cites their observations to label the program as fraud:

The program was designed to have a minimum staffing of counselors and managers but was never properly staffed, the lawsuit states. Required training wasn’t completed. To create an appearance of compliance, employees would be shifted around when corrections supervisors would visit.

Assessments were completed without meeting with prisoners. Supervisors ordered that one-on-one counseling be skipped in favor of group work to maintain appearances. Some group sessions had no counselor and were led by the participants. 

What was supposed to be regimented counseling work became prisoners completing worksheets on their own. And generally, the lawsuit states that medical records, staffing records, assessment documents, participation records were all fabricated to create a “charade” of compliance. 

Brian Whiteside is a prisoner at Howard R. Young Correctional Center. He has struggled with addiction, overdosed in prison and participated in the Road to Recovery Program. 

“It is not a program,” he said in an interview. “It is a money grab.”

He said the contractor employees did not follow the rules for how the program is supposed to work, mental health counseling that is supposed to come with the medication is sparse and the result is many participants return to prison after or die of an overdose on the outside. 

“It was a joke. There is no accountability. The process doesn’t work,” he said.

The lawsuit also includes Rayne and Basara’s observations about the delivery of general healthcare.

It states sick calls were not attended to in a timely and that they had to pester correctional staff to pressure their higher-ups to attend to ailing prisoners. One prisoner with colon cancer couldn’t get an outside colonoscopy, would regularly soil himself, flies hovered around him and his sick call went unanswered for two weeks, the lawsuit states.

The lawsuit tells the story of one prisoner whose cancer caused him to deteriorate, but he could not get proper help until he was hospitalized and believed by the plaintiffs to have died. The lawsuit claims officials let him deteriorate to shift the cost for palliative care onto Medicaid through an extended hospitalization.

“Centurion’s strategy across the state of Delaware was to deny inmates the care they needed in an effort to shift financial responsibility onto Medicaid when inmates became seriously ill and required hospitalization,” the lawsuit states. 

The lawsuit also accuses Centurion of causing addiction by putting prisoners who were not suffering from a substance abuse problem onto addictive drugs designed to treat opioid conditions. It claims a prisoner with a heart condition and another suffering from schizophrenia had their prescribed drugs withheld in favor of opioid abuse medications. 

“Inmates were told repeatedly the drugs they needed were too expensive,” the lawsuit states. 

Big money stakes:

The lawsuit states that Rayne and Basara were both “constructively terminated” in September 2022 after they complained about failures in care. They filed their lawsuit about a year later under what is known as the Delaware False Claims and Reporting Act law.

The law is modeled after a similar federal law that incentivizes whistleblowers to point out individuals or companies that make false claims aimed at defrauding the government. It awards the whistleblowers a percentage of spoils if the lawsuit is successful. In this case, the whistleblowers could receive up to 25 percent of the proceeds.

Litigation under the False Claims Act classifies whistleblowers like Rayne and Basara as “relators” and the state as the plaintiff.

After the lawsuit was filed under seal in September 2023, civil attorneys under Jennings, the state’s top legal officer, began an investigation into the allegations to answer whether the state would join the lawsuit.

Washington D.C.-based attorney Reuben Guttman represents Rayne and Basara and is considered an expert in this type of litigation. He said the government choosing to intervene generally tells the court that the allegations are “material” and “important.”

“You have a lot of private vendors that have come into the (prison) healthcare area and offered the quick fix. Quite frankly, there is no quick fix,” Guttman said. “It is an unfortunate situation, and it is important that the state has stepped in and is taking on these defendants.”

The lawsuit seeks three times what the court may rule as the amount of damages the government sustained because of the fraud as well as the “disgorgement” of all money resulting from the company’s “wrongful conduct.”

State records indicate Centurion was paid $206 million over the course of the contract.

Centene sold off its prison healthcare business in 2023 at what court records indicate was a fire sale price. And there is an ongoing, separate court fight in Delaware’s Chancery Court over who has to pay still-growing costs associated with claims of malpractice and negligent care from when Centene owned the business.

Centene, a publicly traded company, has argued that the terms of the sale means the business’ buyer, a private conglomerate of construction and government contracting businesses owned by a Texas family, should have to pick up the bill.

The Sullivan Brothers Family of Companies accused Centene of obscuring the scale of the negligence claims against the business before the sale and twisting the purchase contract’s language in an unfair attempt to pin costs associated with those long-running medical negligence claims on them.

Why care?

Prisoners are stripped of their freedom for a period of incarceration by a judge, but are not sentenced to medically suffer or potentially die at an earlier age due to neglect. The U.S. Supreme Court has also interpreted amendments to the U.S. Constitution to imbue those imprisoned with a right to basic healthcare and humane conditions. 

And the cost to provide care for people in prison is one of the largest borne by society in today’s carceral system − totaling well more than $50 million a year from state coffers in Delaware.

And while this lawsuit is unique because of the state’s involvement, the allegations are not new for Centurion or Delaware prison healthcare providers before or after.

The allegations follow a similar narrative told by prisoners in interviews with DelawareOnline/The News Journal as well as large-scale litigation against Centurion, VitalCore Health Strategies, the current healthcare provider, and Connections before those two. 

In 2023, the local chapter of the ACLU sued Centurion and VitalCore accusing the contractors of understaffing and delaying basic and outside care and consultation to the point of permanent health consequences. It seeks to represent every prisoner that has been incarcerated while those two have worked for the state.

That lawsuit is ongoing. It comes after a host of other lawsuits and settlements regarding Delaware’s prison healthcare that continue to trickle in against Centurion and providers all the way back to Connections.

In February, the insurer for the now bankrupt Connections settled a prison healthcare lawsuit filed all the way back in 2020 by the family of a 35-year-old man who died of what his lawsuit described as violently obvious opiate withdrawals after a day and a half of being jailed on driving charges.

Whiteside, a prisoner at Howard R. Young, said the system remains disjointed, people don’t receive the care they need and he fears that it is designed to discourage people from seeking care. He said the system leaves people feeling “defeated, deflated and overwhelmed.”

“If you want healthcare you have to fight,” he said. “You have to advocate for yourself. You have to put multiple sick calls in and most people get tired of the process,”

He said people on the outside should care because prisoners are not sentenced to suffer medically and that prison is supposed to include rehabilitation.

“Prison is not supposed to be easy, not supposed to be comfortable,” he said. “But the punishment is being away from our families.” 

Contact Xerxes Wilson at (302) 324-2787 or xwilson@delawareonline.com. Delaware prisoners may also contact Xerxes Wilson on the GettingOut app.

Source: https://www.aol.com/articles/state-backed-whistleblower-suit-claims-082033236.html

April 28, 2026 By Staff

CLE: Essential Evidence Rules for Today’s Litigators

This presentation provides litigators with a practical, strategy-focused overview of essential Federal Rules of Evidence encountered in modern litigation. Through selected rules governing relevance, hearsay, documents, judicial notice, and presentation of proof, the session emphasizes how evidentiary decisions affect case development from investigation through trial. The program is designed to enhance both advocacy skills and evidentiary judgment in real-world litigation settings.

June 3, 1:00 PM ET/10:00 AM PT, 90 minute webinar

  • Why Evidence Rules Matter from Case Intake to Trial
    • Overview of how the Federal Rules of Evidence shape litigation strategy from evaluating claims through trial and appeal.
    • Setting the framework for the rules discussed in the session.
  • Relevance and Exclusion of Evidence: FRE 401 and 403
    • Explanation of relevance as a foundational evidentiary concept.
    • Discussion of how courts balance probative value against unfair prejudice, confusion, and waste of time.
  • Completing the Picture and Presenting Evidence Effectively: FRE 106 and 107
    • Discussion of the Rule of Completeness and the strategic use of illustrative aids.
    • Explanation of how advocates can prevent misleading presentations and assist the factfinder without creating unfair prejudice.
  • Judicial Notice and Proof of Facts: FRE 201
    • Examination of judicial notice, including what facts qualify and how and when notice may be taken.
    • Discussion of the different consequences in civil versus criminal cases.
  • Documents and the Best Evidence Rule: FRE 1002
    • Review of when originals are required, and when duplicates or summaries may suffice.
    • Examination of how litigators can manage voluminous records efficiently.
  • Hearsay Foundations and Key Exceptions: FRE 801 and 803
    • Analysis of hearsay definitions, non-hearsay exclusions, and commonly invoked exceptions.
    • Exceptions to be discussed include business records, public records, medical treatment statements, and market reports.
  • Authentication of Evidence: FRE 901
    • Practical guidance on authenticating evidence through witness testimony, distinctive characteristics, handwriting, voice identification, and other commonly used methods.
    • Discussion of how to authenticate in a meaningful way that advances case themes and theories.
  • Summaries to Prove Content: FRE 1006
    • Discussion of when to use summaries and how to use them effectively.
    • Review of when originals are required.
    • Examination of how litigators can manage voluminous records efficiently.
  • Q&A (As Time Permits)

Speakers

About Veronica Finkelstein
Professor
Wilmington University School of Law

Veronica J. Finkelstein combines the best of practice and teaching, devoting herself to developing the next generation of top advocates. She is both an experienced litigator and a skilled educator with diverse scholarly interests. Finkelstein spent a majority of her career as an Assistant U.S. Attorney with the U.S. Attorney’s Office for the Eastern District of Pennsylvania before transitioning to a full-time teaching role at the Wilmington University School of Law. She remains a Litigative Consultant to the U.S. Department of Justice, assisting with the Civil Division’s most complex cases.

At the U.S. Attorney’s Office, she served as the civil division training officer and paralegal supervisor for the Civil Division before being selected as senior litigation counsel. Finkelstein handled various civil affirmative and defensive matters and criminal child exploitation cases. She tried numerous civil cases to defense verdicts, including tort, employment law, and medical malpractice. She successfully litigated cases on appeal, including Groff v. DeJoy which she briefed, argued, and won before the United States Court of Appeals for the Third Circuit. The Supreme Court subsequently granted certiorari and clarified the applicable standard before remanding the case.

In addition to this defensive work, Finkelstein investigated and prosecuted affirmative fraud claims, including qui tam actions. In 2014 she was awarded the Executive Office of United States Attorneys Director’s Award for Superior Performance as a Civil Assistant U.S. Attorney. Before joining the U.S. Attorney’s Office, Finkelstein clerked for the Honorable Jane Cutler Greenspan on the Pennsylvania Supreme Court.

She previously worked as a construction litigator at Duane Morris, LLP and Cohen Seglias Pallas Greenhall & Furman, PC. A gifted teacher who regularly works with both lawyers and law students, Finkelstein has taught at the U.S. Department of Justice’s National Advocacy Center on legal writing, ethics, appellate advocacy, and trial practice. She frequently serves as a program director for the National Institute for Trial Advocacy, where she teaches legal writing, deposition, motion practice, and trial advocacy programs.

Prior to entering academia full time, Finkelstein served as adjunct faculty of law at Drexel Law, Emory Law, and Rutgers Law. She was awarded the Carl “Tobey” Oxholm III Outstanding Contribution to the Thomas R. Kline School of Law Community Award in 2021 and was named Rutgers Law School Adjunct Professor of the Year every year she taught at Rutgers Law.

Finkelstein’s scholarship is as diverse as her litigation and teaching experience. Her scholarship has addressed various topics, from civil procedure to constitutional law. She is the co-author of the Professional Responsibility textbook “Ethical Lawyering: A Guide for the Well-Intentioned,” which contextualizes the rules of professional conduct in realistic litigation settings as well as “Case Closed: A Practical Guide to Mastering Pretrial Advocacy,” a hands-on roadmap for litigators navigating the most critical — and often outcome‑determinative — phase of a lawsuit: pretrial practice.

Finkelstein graduated, with honors, from the Emory University School of Law. She was a highly competitive member of Emory Law’s moot court society and was selected for the Order of the Barristers. She received her undergraduate degrees in English and Speech Communication from the Pennsylvania State University. She is currently pursing a Master of Law’s degree from Columbia Law School.

Reuben Guttman
Founding Member
Guttman & Buschner, PLLC

Reuben Guttman is a founding member of Guttman & Buschner, PLLC where — in addition to mediating cases — his practice involves civil rights, whistleblowers, class actions and complex litigation.

The International Business Times has referred to him as “one of the world’s most prominent whistleblower attorneys.” Citing “wins recouping billions of dollars for the federal and state governments,” STAT News referred to him as the “The Lawyer Pharma Loves to Hate.”

Guttman has represented workers, unions, and pension funds in complex litigation. For over a decade, he served as the chief outside counsel to the Oil, Chemical & Atomic Workers International Union, AFL-CIO/CLC, in a series of labor and environmental cases that enhanced safety and environmental conditions at Manhattan Project nuclear weapons sites while driving dread disease compensation legislation for nuclear weapons workers across the nation.

In 2020, he served as lead counsel in a federal class action lawsuit against the South Carolina Department of Corrections and secured a consent order mandating Hepatitis C testing and treatment for 17,000 inmates.

His defense work has included First Amendment work for a newspaper group and jury trial civil fraud defense.

Guttman is currently a faculty member of the American University School of Public Affairs where he teaches Equal Protection/Civil Rights, and he has been an Adjunct Professor at Emory Law School and a Senior Fellow at Emory Law’s Center for Advocacy and Dispute Resolution. He is a Founder and Senior Advisor to the Emory Corporate Governance and Accountability Review (ECGAR). He is the 2015 recipient of the Emory Law Alumni Service Award.

He has taught trial advocacy and complex case investigations in the United States, China, and Mexico, and he has co-authored three case files – two published by Emory Law and one published by the National Institute of Trial Advocacy where he is a faculty member.

He is co-author (with J.C. Lore III of Rutgers Law) of the textbook, Pretrial Advocacy (Wolters Kluwer Spring, 2021). He is a chapter co-author (with Traci Buschner) and wrote the introduction for Remote Advocacy: A Guide to Survive and Thrive (Wolters Kluwer and National Institute of Trial Advocacy, 2020). He is co-author of False Claims Act: Representing the Plaintiffs (LEXIS/NEXIS Practice Guide, 2025).

Guttman has written or co-authored more than 100 articles or opinion pieces and multiple book chapters and law review pieces. He has been a columnist for Law360 where he writes on litigation and politics, and he has been a columnist for the Global Legal Post.

His article, Pharmaceutical Regulation in the United States; a Confluence of Influences, was translated and published in Mandarin in the Peking University Public Interest Law Journal, Vol 1, Page 187 (2010).

Guttman is a Fellow of the American Bar Foundation; he is past member of the Board of Directors of the American Constitution Society (ACS) where he is currently a member of the ACS Board of Advisors.

Guttman received his JD from Emory University and his BA in American History from the University of Rochester. He is the founder of www.whistleblowerlaws.com.

He began his legal career as a Washington DC counsel for the Service Employees International Union, AFL-CIO, where he served for five years. Guttman is licensed to practice in front of The United States Supreme Court and in Georgia, New Jersey, Pennsylvania, and the District of Columbia.

Presented by Justia Connect. Click Here to Register and for more information.

December 29, 2025 By Staff

CLE: Why Mediation Fails and How to Fix It: A Strategic, Political, and Practical Approach to Case Resolution | myLawCLE

Whether through settlement, or adjudication, all disputes have an end point. Sometimes the litigation process is necessary to help the parties find that end point but often a neutral, or mediatory, is necessary to navigate the politics of the dispute which are often tempered by economics, emotions, and the dynamics of decision making inherent in institutional plaintiffs or defendants. At some point, parties in dispute find themselves asking this question about their opposition: “what’s really going on behind the scenes and who is calling or influencing the shots?” The problem, of course, is that the influences may be subtle, subconscious, or not otherwise clear the parties themselves. This 2-hour program will focus on the politics of mediation as a process to resolve cases; narrow issues in dispute; or gain insight into the relevant facts that will decide the case. The program will answer questions about the politics of mediation, and provide a contemporary perspective, setting the tone for a less adversarial process and one designed to reach a business solution.

To register or learn more visit: https://mylawcle.com/products/why-mediation-fails-and-how-to-fix-it-a-strategic-political-and-practical-approach-to-case-resolution/

Key topics to be discussed:

  • Where does the client need to end up?
  • Which cases are best suited for mediation?
  • What are the politics governing settlement?
  • When is it time to mediate?
  • How do you select a mediator?
  • The formats for mediation?
  • Cutting the issues?
  • The role of counsel and clients?
  • Mediation as a fact-finding mechanism?
  • Mediation as a settlement process?

Date / Time: January 23, 2026

  • 1:00 pm – 3:10 pm Eastern
  • 12:00 pm – 2:10 pm Central
  • 11:00 am – 1:10 pm Mountain
  • 10:00 am – 12:10 pm Pacific

Reuben Guttman | Guttman, Buschner & Brooks PLLC

Reuben Guttman is a founding member of Guttman& Buschner, PLLC where – in addition to mediating cases – his practice involves civil rights, whistleblowers, class actions and complex litigation. The International Business Times has referred to him as “one of the world’s most prominent whistleblower attorneys.” Citing “wins recouping billions of dollars for the federal and state governments,” STAT News referred to him as the “The Lawyer Pharma Loves to Hate.”

Guttman has represented workers, unions, and pension funds in complex litigation. For over a decade, he served as the chief outside counsel to the Oil, Chemical & Atomic Workers International Union, AFL-CIO/CLC, in a series of labor and environmental cases that enhanced safety and environmental conditions at Manhattan Project nuclear weapons sites while driving dread disease compensation legislation for nuclear weapons workers across the nation. In 2020, he served as lead counsel in a federal class action lawsuit against the South Carolina Department of Corrections and secured a consent order mandating Hepatitis C testing and treatment for 17,000 inmates. His defense work has included First Amendment work for a newspaper group and jury trial civil fraud defense.

Guttman is currently a faculty member of the American University School of Public Affairs where he teaches Equal Protection/Civil Rights, and he has been an Adjunct Professor at Emory Law School and a Senior Fellow at Emory Law’s Center for Advocacy and Dispute Resolution. He is a Founder and Senior Advisor to the Emory Corporate Governance and Accountability Review (ECGAR). He is the 2015 recipient of the Emory Law Alumni Service Award. He has taught trial advocacy and complex case investigations in the United States, China, and Mexico, and he has co-authored three case files – two published by Emory Law and one published by the National Institute of Trial Advocacy where he is a faculty member.

He is co-author (with J.C. Lore III of Rutgers Law) of the textbook, Pretrial Advocacy (Wolters Kluwer Spring, 2021). He is a chapter co-author (with Traci Buschner) and wrote the introduction for Remote Advocacy: A Guide to Survive and Thrive (Wolters Kluwer and National Institute of Trial Advocacy, 2020). He is co-author of False Claims Act: Representing the Plaintiffs (LEXIS/NEXIS Practice Guide, 2025). Guttman has written or co-authored more than 100 articles or opinion pieces and multiple book chapters and law review pieces. He has been a columnist for Law360 where he writes on litigation and politics, and he has been a columnist for the Global Legal Post.

His article, Pharmaceutical Regulation in the United States; a Confluence of Influences, was translated and published in Mandarin in the Peking University Public Interest Law Journal, Vol 1, Page 187 (2010). Guttman is a Fellow of the American Bar Foundation; he is past member of the Board of Directors of the American Constitution Society (ACS) where he is currently a member of the ACS Board of Advisors. Guttman received his JD from Emory University and his BA in American History from the University of Rochester. He is the founder of www.whistleblowerlaws.com.

He began his legal career as a Washington DC counsel for the Service Employees International Union, AFL-CIO, where he served for five years. Guttman is licensed to practice in front of The United States Supreme Court and in the states of Georgia, New Jersey, Pennsylvania, the District of Columbia.

John Harrison | Evans Harrison Hackett PLLC

John Harrison has been in the private practice of law in Chattanooga, Tennessee for over 45 years. His practice consists of representing clients in litigation involving discrimination claims, retaliation claims, wrongful discharge claims, employment contracts, and employment torts; advising clients on employment and labor law compliance; representing clients in general business and commercial litigation; and representing management in union matters, including union avoidance, unfair labor practice charges, labor organizing efforts, union representation elections, collective bargaining, strikes, and labor arbitrations.

John has been listed in The Best Lawyers in America® in Labor and Employment Law since 2007. John is listed in Mid-South Super Lawyers® in Employment & Labor, Employment Litigation: Defense, and Alternative Dispute Resolution. John is a Tennessee Supreme Court Rule 31-Listed General Civil Mediator. John is a Master in the Ray L. Brock and Robert E. Cooper American Inn of Court.

To register or learn more visit: https://mylawcle.com/products/why-mediation-fails-and-how-to-fix-it-a-strategic-political-and-practical-approach-to-case-resolution/

December 29, 2025 By Staff

CLE: Pharmaceutical and Medical Device Litigation: Accountability, Promotion, and Fraud Case Studies | myLawCLE

This two-hour panel program is divided into three sessions examining pharmaceutical accountability and the industry’s influence on healthcare. The panel explores the evolution of pharmaceutical and medical device litigation, the impact of promotional practices on medical decision-making, and the investigation of pharmaceutical fraud through landmark case studies. Together, the sessions provide a practical, attorney-focused overview of how litigation, regulation, and enforcement address the tensions between commercial interests and patient care in the pharmaceutical industry.

To register or learn more visit: https://mylawcle.com/products/pharmaceutical-and-medical-device-litigation-accountability-promotion-and-fraud-case-studies/

Session I – Pharmaceutical and Medical Device Litigation

In the 1960’s the growth of the consumer movement opened the door to legitimacy of questioning whether injury may be attributable to the conduct of product developers and manufacturers. In 1962, FDA Pharmacologist and Physician, Dr. Francis Kelsey, was recognized by President Kennedy for blocking the sale of Thalidomide in the United States after it was determined that the drug – often used in pregnancy — caused severe birth defects. Over half century has passed since the work of Dr Kelsey and during that period litigation and the Congressional oversight has – to some degree – exposed the internal workings of the pharmaceutical and medical device industry and impact of tensions between commercial obligations and patient care.

We will explore the tensions that drive impropriety and their impact on standards of care and practices including treatment at long term care facilities. From False Claims Act cases to Multi-District Litigation, including nuisance claims, the program will touch on the breadth of litigation.

Key topics to be discussed:

  • The drivers that spur impropriety including Wall Street obligations
  • How standards of care are being impacted
  • The role of government litigation
  • The investigation of cases
  • Key evidentiary issues
  • Key procedural issues

Session II – How Pharma Affects Medical Knowledge and Medical Practice

We will explore how pharmaceutical marketing influences medicine and public perception beyond traditional advertising. Focusing on PharmedOut’s research, the session examines covert promotional tactics such as sponsored education, ghostwriting, and key opinion leader campaigns. It also addresses how pharmaceutical companies may broaden or redefine medical conditions to expand drug markets. Attorneys will gain insight into the legal, ethical, and evidentiary implications of these practices, with practical relevance to healthcare regulation, litigation, and professional responsibility.

Key topics to be discussed:

  • PharmedOut’s work
  • Covert forms of pharmaceutical promotion
  • How Pharma invents diseases

Session III – Case Studies in the Investigation of Pharmaceutical Fraud: Purdue Pharma (Oxycontin) and Abbott Laboratories (Depakote)

This session uses Purdue Pharma (OxyContin) and Abbott Laboratories (Depakote) as case studies to examine how major pharmaceutical fraud investigations develop and unfold. Attendees will explore the origins of each case, parallel civil and criminal investigation strategies, and the role of documents and witnesses in building or defending these matters. The program emphasizes why pharmaceutical fraud cases often turn on claims and reimbursement data—underscoring the principle that, in the end, “it’s the claims.”

Key topics to be discussed:

  • Case origin
  • Parallel investigation techniques
  • Documents
  • Witnesses
  • “It’s the claims, stupid”

Date / Time: January 30, 2026

  • 1:00 pm – 3:20 pm Eastern
  • 12:00 pm – 2:20 pm Central
  • 11:00 am – 1:20 pm Mountain
  • 10:00 am – 12:20 pm Pacific

To register or learn more visit: https://mylawcle.com/products/pharmaceutical-and-medical-device-litigation-accountability-promotion-and-fraud-case-studies/

Adriane Fugh-Berman, MD | Georgetown University Medical Center

Adriane Fugh-Berman, MD is a Professor of Pharmacology and Physiology and the Department of Family Medicine at Georgetown University Medical Center. Dr. Fugh-Berman codirects the M.S. program in Health and the Public Interest and directs PharmedOut, a research and education project at GUMC that promotes rational prescribing and exposes the effect of pharmaceutical marketing on prescribing practices.

Dr. Fugh-Berman has authored many key articles in peer-reviewed literature on the area of industry influence on medicine, including the first studies in the medical literature about how the pharmaceutical industry influences surgeons, pharmacists, basic scientists, and individual patients. Other key articles address industry influence on continuing medical education, studies of messaging in CME on shortacting opioids, fentanyl, binge-eating disorder, and hypoactive sexual desire disorder; a national survey of dentists’ attitudes about opioids, a study that shows that Medicare prescribers who accept industry gifts prescribe more medications (and more expensive medications), a review of how industry uses social psychology to manipulate physicians, an exposé of how ghostwritten articles in the medical literature were used to sell menopausal hormone therapy, an article about how “key opinion leaders” are used to market drugs off-label, an explanation of drug rep tactics, a national survey of industry interactions with family medicine residencies, and a study of the first educational activity that changed physicians’ perceptions about their own individual vulnerability to pharmaceutical marketing. Dr. Fugh-Berman lectures internationally and has appeared on 20/20, Nightline, the 1A, the Diane Rehm show, and every major television network.

Previously, Dr. Fugh-Berman was a medical officer in the Contraception and Reproductive Health Branch of the National Institute for Child Health and Human Development, NIH. She has also worked with the nonprofit Reproductive Toxicology Center and edited an award-winning CME newsletter on women’s health. Dr. Fugh-Berman graduated from Georgetown University School of Medicine and completed a family medicine internship in the Residency Program in Social Medicine at Montefiore Hospital in the Bronx.

Reuben Guttman | Guttman Buschner PLLC

Reuben Guttman is a founding member of Guttman, Buschner & Brooks, PLLC where his practice involves civil rights, whistleblowers, class actions and complex litigation. The International Business Times has referred to him as “one of the world’s most prominent whistleblower attorneys.” Citing “wins recouping billions of dollars for the federal and state governments,” Boston Globe’s STAT News referred to him as the “The Lawyer Pharma Loves to Hate.”

Guttman has represented workers, unions, and pension funds in complex litigation. For over a decade, he has served as the chief outside counsel to the Oil, Chemical & Atomic Workers International Union, AFLCIO/CLC, in a series of labor and environmental cases that enhanced safety and environmental conditions at Manhattan Project nuclear weapons sites while driving dread disease compensation legislation for nuclear weapons workers across the nation.

In 2020, he served as lead counsel in a federal class action lawsuit against the South Carolina Department of Corrections and secured a consent order mandating Hepatitis C testing and treatment for 17,000 inmates.

Guttman is currently a faculty member of the American University School of Public Affairs where he teaches Equal Protection/Civil Rights, and he has been an Adjunct Professor at Emory Law School and a Senior Fellow at Emory Law’s Center for Advocacy and Dispute Resolution. He is a Founder and Senior Advisor to the Emory Corporate Governance and Accountability Review (ECGAR). He is the 2015 recipient of the Emory Law Alumni Service Award.

He has taught trial advocacy and complex case investigations in the United States, China, and Mexico, and he has co-authored three case files – two published by Emory Law and one published by the National Institute of Trial Advocacy where he is a faculty member.

He is co-author (with J.C. Lore III of Rutgers Law) of the textbook, Pretrial Advocacy (Wolters Kluwer Spring, 2021). He is a chapter co author (with Traci Buschner) and wrote the introduction for Remote Advocacy: A Guide to Survive and Thrive (Wolters Kluwer and National Institute of Trial Advocacy, 2020).

Guttman has written or co-authored more than 100 articles or opinion pieces and multiple book chapters and law review pieces. He is a monthly columnist for Law360 where he writes on litigation and politics. His article, Pharmaceutical Regulation in the United States; a Confluence of Influences, wastranslated and published in Mandarin in the Peking University Public Interest Law Journal, Vol 1, Page 187 (2010).

Guttman is a Fellow of the American Bar Foundation; he is past member of the Board of Directors of the American Constitution Society (ACS) where he is currently a member of the ACS Board of Advisors. Guttman received his JD from Emory University and his BA in American History from the University of Rochester. He is the founder of www.whistleblowerlaws.com. He began his legal career as a Washington, DC counsel for the Service Employees International Union, AFL-CIO, where he served for five years.

Rick Mountcastle | Guttman Buschner PLLC

Former United States Attorney Rick Mountcastle joined Guttman Buschner LLP as Of Counsel in April 2025, after retiring from the United States Attorney’s Office for the Western District of Virginia and the Virginia Attorney General’s Office.

An award-winning Federal criminal and civil litigator with more than 30 years of experience litigating the most complex and intricate cases, Rick was portrayed by Emmy-nominated actor Peter Sarsgaard in the 2021 awardwinning Hulu miniseries “Dopesick,” which chronicles his leadership of the 2007 prosecution of notorious OxyContin maker Purdue Pharma and its three top executives. He has spoken about the case and the events surrounding the opioid crisis on CBS’s 60 Minutes (aired March 9, 2025), at Law School events, and on numerous podcasts.

Rick’s Federal experience included almost nine years as an award-winning Senior Trial Attorney in DOJ’s Tax Division where he prosecuted complex criminal tax cases across the country. He received several awards, most notably DOJ’s highest honor, the Attorney General’s John Marshall Award for the Trial of Litigation, for leading the prosecution of a Russian mafia leader in the Eastern District of New York for gasoline excise tax fraud conspiracy. In 2007, after more than twenty years and more than 50 jury trials as a criminal prosecutor, Rick moved to the U.S. Attorney’s Office’s Civil Division in Roanoke, Virginia, where he built the office’s False Claims Act and Affirmative Civil Enforcement program while supervising the Financial Litigation Unit and defending the United States in medical malpractice, personal injury, civil rights, and other civil matters. Most notably, he led the False Claims Act and criminal prosecution of Abbott Laboratories for fraudulently marketing Depakote (an anti-epileptic) for off-label treatment of agitation related to dementia in nursing home residents. Working closely with relator’s counsel, Reuben Guttman and Traci Buschner, he secured $1.5 Billion in civil and criminal penalties, at the time the largest single-drug settlement of an off-label pharmaceutical fraud case in the history of the Department of Justice.

Rick also served as the Civil Chief (2010-2016), First Assistant U.S. Attorney (2016-2017, 2018), and Principal Deputy U.S. Attorney (2018). He was appointed the United States Attorney for the Western District of Virginia January 2017 through March 2018. During his tenure he led the Federal response to the August 12, 2017 violence in Charlottesville, initiated the office’s opioid overdose prevention outreach program, directed and oversaw the reorganization of the office’s domestic terrorism and crisis response plan, initiated an anti-gang task force pairing Federal law enforcement with the Danville, Virginia, police department, and initiated a partnership with the Federal Court and the Federal Public Defender to identify and rectify potential discovery issues in a series of dozens of prior criminal prosecutions. Following his retirement from federal service, Rick served three years as an Assistant Attorney General for Virginia’s Medicaid Fraud Control Unit conducting False Claims Act investigations.

Since June 2022, he has partnered with Los Angeles filmmakers Susie Singer Carter and Don Priess to produce the docuseries “No Country for Old People-A Nursing Home Exposé,” which chronicles the plight of our elderly and disabled in nursing homes. The docuseries is currently streaming on Amazon Prime Video, Tubi, and other streaming platforms.

Rick, a graduate of Marquette University and the George Washington University National Law Center, began his career serving four years on active duty in the United States Army Judge Advocate General Corps (JAG) and served an additional 24 years as an U. S. Army Reserve JAG, retiring as a Lieutenant Colonel in 2008.

To register or learn more visit: https://mylawcle.com/products/pharmaceutical-and-medical-device-litigation-accountability-promotion-and-fraud-case-studies/

November 17, 2025 By Staff

CLE: Do You Have an Employment LawCase? Reimagining Employment Law Intake and Client Communication with AI

Session I – Transforming Law Firm Operations with Intelligent Automation: A Case Status Demo – Jose Figueroa

A Case Status demo walks you through how our intelligent client experience platform transforms law firm operations. You’ll see how branded, mobile-first communication, powered by AI and automation, eliminates manual updates, reduces client calls, and boosts satisfaction—helping firms scale without adding headcount. It’s not just a demo—it’s a glimpse into a more efficient, client-centric future.

Key topics to be discussed:

  • Operational efficiency at scale
  • Elevated client experience
  • Growth without additional headcount

Session II – Optimizing Client Intake in Employment Law: From Inquiry to Engagement – Reuben A. Gutman

Reuben Guttman’s session will focus on the client intake process in employment law, emphasizing how intuitive screening and structured evaluation form the foundation for effective representation. He will outline how breaking down each case by type—discrimination, wage and hour, ERISA, whistleblower, and class versus individual claims—helps determine the case’s scope, strategy, and suitability. His framework underscores the importance of careful questioning and early issue spotting to ensure clarity and alignment between attorney and client from the outset.

Key topics to be discussed:

  • Discrimination
  • Wage and Hour
  • ERISA
  • Whistleblower
  • Class vs. Individual

Date / Time: November 21, 2025

  • 1:00 pm – 3:10 pm Eastern
  • 12:00 pm – 2:10 pm Central
  • 11:00 am – 1:10 pm Mountain
  • 10:00 am – 12:10 pm Pacific

To register or for more information visit: https://federalbarcle.org/product/do-you-have-an-employment-lawcase-reimagining-employment-law-intake-and-client-communication-with-ai/

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

Information

  • Where to Start
  • Whistleblower Information
  • Federal & State False Claims Acts
  • Protecting Whistleblowers
  • CLE for Attorneys

Law Flash

What to DOGE about Fraud, Waste, and Abuse?

Unless you’ve been living under a rock, you’ve seen the headlines. “Department of Defense pays $32,000 to replace 25 coffee cups.” “Boeing overcharges Air Force by 8,000% for soap dispensers.” While … [Read More...] about What to DOGE about Fraud, Waste, and Abuse?

Footer

Guttman Buschner PLLC

Washington DC Office
Embassy Row District
1509 22nd Street, NW
Washington, D.C. 20037
Phone: 202-800-3001

Home
Areas of Practice
Successes
Articles
Attorneys & Advisors
CLE Seminars
Amicus
Videos
Contact Us
On Demand CLE: Reuben Guttman, and Professor JC Lore present CLE covering topics in their book, Pretrial Advocacy, Wolters Kluwer-NITA (2021).”
To learn More
More about the book here
More CLEs by GB Attorneys

Articles

State-backed whistleblower suit claims neglect in Delaware prison care

CLE: Essential Evidence Rules for Today’s Litigators

CLE: Why Mediation Fails and How to Fix It: A Strategic, Political, and Practical Approach to Case Resolution | myLawCLE

More Articles

Copyright © 2026 · Guttman Buschner PLLC
Disclaimer